Abstract | OBJECTIVE: DESIGN: Randomized, double-blind, placebo-controlled, parallel group trial. SETTING: Outpatient tertiary care center. PATIENTS: 64 patients meeting DSM-III criteria for multi-infarct dementia with modified Hachinski ischemic scores greater than or equal to 6, 38 of whom completed the trial. INTERVENTION: MAIN OUTCOME MEASURE: RESULTS: Baseline demographic values and psychometric variables were similar in the placebo and control groups; endpoint statistical analysis was used to allow the use of data from all patients in this clinically high-risk group. For the total group, the slowing of deterioration did not reach statistical significance (by 2-tailed t test), as measured by scores on the total ADAS (P = 0.058) or on the cognitive (ADAS items 1-11; P = 0.064) or non-cognitive subscales (ADAS items 12-21; P = 0.234), although it was significant on the cognitive subscales excluding memory (ADAS items 2-6, 8-10; P = 0.036). For the subgroup of 40 patients who had CT and/or MRI evidence of stroke as well as meeting the other inclusion criteria, treatment with pentoxifylline was associated with significantly slower deterioration, as measured by the total ADAS (P = 0.023) and cognitive subscores (P = 0.020) but not non-cognitive subscores (P = 0.118). For the subgroup of 37 patients who had at least one discrete clinical stroke, treatment with pentoxifylline was associated with significantly less deterioration on the total ADAS (P = 0.002) and both the cognitive (P = 0.001) and non-cognitive (P = 0.017) subscores. CONCLUSION:
|
Authors | R S Black, L L Barclay, K A Nolan, H T Thaler, S T Hardiman, J P Blass |
Journal | Journal of the American Geriatrics Society
(J Am Geriatr Soc)
Vol. 40
Issue 3
Pg. 237-44
(Mar 1992)
ISSN: 0002-8614 [Print] United States |
PMID | 1538042
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Academic Medical Centers
- Administration, Oral
- Aged
- Aged, 80 and over
- Cognition
- Dementia, Multi-Infarct
(diagnosis, drug therapy, etiology)
- Double-Blind Method
- Female
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neuropsychological Tests
- New York
- Outpatient Clinics, Hospital
- Pentoxifylline
(administration & dosage, pharmacology, therapeutic use)
- Rehabilitation Centers
- Severity of Illness Index
- Tomography, X-Ray Computed
|